These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 22210181)

  • 1. Inflammation and immune surveillance in cancer.
    Chow MT; Möller A; Smyth MJ
    Semin Cancer Biol; 2012 Feb; 22(1):23-32. PubMed ID: 22210181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine-based transformation of immune surveillance into tumor-promoting inflammation.
    Mumm JB; Oft M
    Oncogene; 2008 Oct; 27(45):5913-9. PubMed ID: 18836472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Balancing the innate immune system in tumor development.
    Hagerling C; Casbon AJ; Werb Z
    Trends Cell Biol; 2015 Apr; 25(4):214-20. PubMed ID: 25444276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NLRP3 Inflammasome: A Possible Link Between Obesity-Associated Low-Grade Chronic Inflammation and Colorectal Cancer Development.
    Ahechu P; Zozaya G; Martí P; Hernández-Lizoáin JL; Baixauli J; Unamuno X; Frühbeck G; Catalán V
    Front Immunol; 2018; 9():2918. PubMed ID: 30619282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.
    Schreiber RD; Old LJ; Smyth MJ
    Science; 2011 Mar; 331(6024):1565-70. PubMed ID: 21436444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammasomes: Emerging Central Players in Cancer Immunology and Immunotherapy.
    Karan D
    Front Immunol; 2018; 9():3028. PubMed ID: 30631327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering the loop of epithelial-mesenchymal transition, inflammatory cytokines and cancer immunoediting.
    Sistigu A; Di Modugno F; Manic G; Nisticò P
    Cytokine Growth Factor Rev; 2017 Aug; 36():67-77. PubMed ID: 28595838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-Like Receptors Signaling in the Tumor Microenvironment.
    McCall KD; Muccioli M; Benencia F
    Adv Exp Med Biol; 2020; 1223():81-97. PubMed ID: 32030686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate immunity, inflammation and tumour progression: double-edged swords.
    Mantovani A; Ponzetta A; Inforzato A; Jaillon S
    J Intern Med; 2019 May; 285(5):524-532. PubMed ID: 30873708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensing between reactions - how the metabolic microenvironment shapes immunity.
    Lötscher J; Balmer ML
    Clin Exp Immunol; 2019 Aug; 197(2):161-169. PubMed ID: 30868561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural innate and adaptive immunity to cancer.
    Vesely MD; Kershaw MH; Schreiber RD; Smyth MJ
    Annu Rev Immunol; 2011; 29():235-71. PubMed ID: 21219185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-beta: a master switch in tumor immunity.
    Gigante M; Gesualdo L; Ranieri E
    Curr Pharm Des; 2012; 18(27):4126-34. PubMed ID: 22630082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokine Heterocomplexes and Cancer: A Novel Chapter to Be Written in Tumor Immunity.
    D'Agostino G; Cecchinato V; Uguccioni M
    Front Immunol; 2018; 9():2185. PubMed ID: 30319638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1.
    Chiba S; Baghdadi M; Akiba H; Yoshiyama H; Kinoshita I; Dosaka-Akita H; Fujioka Y; Ohba Y; Gorman JV; Colgan JD; Hirashima M; Uede T; Takaoka A; Yagita H; Jinushi M
    Nat Immunol; 2012 Sep; 13(9):832-42. PubMed ID: 22842346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tumor immunity: myeloid leukocytes control the immune landscape.
    Rutkowski MR; Stephen TL; Conejo-Garcia JR
    Cell Immunol; 2012; 278(1-2):21-6. PubMed ID: 23121972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impaired anti-tumoral effect of immune surveillance cells in the immune microenvironment of gastric cancer.
    Fan X; Jin J; Yan L; Liu L; Li Q; Xu Y
    Clin Immunol; 2020 Oct; 219():108551. PubMed ID: 32739413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of the stroma in the initiation and progression of tumors].
    Baranyi M; Lippai M; Szatmári Z
    Orv Hetil; 2015 Nov; 156(45):1816-23. PubMed ID: 26522855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cytokine-mediated link between innate immunity, inflammation, and cancer.
    Lin WW; Karin M
    J Clin Invest; 2007 May; 117(5):1175-83. PubMed ID: 17476347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immune response to tumors.
    Dougan M; Dranoff G
    Curr Protoc Immunol; 2009 Apr; Chapter 20():20.11.1-20.11.4. PubMed ID: 19347848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NK Cells in the Tumor Microenvironment.
    Guillerey C
    Adv Exp Med Biol; 2020; 1273():69-90. PubMed ID: 33119876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.